Johnson & Johnson's single shot Covid vaccine likely to be in India as early as July

Updated : Jun 27, 2021 08:35
|
Editorji News Desk

Johnson & Johnson's single shot Covid vaccine could be offered by hospitals in India early as July as Association of Private Healthcare Providers in India (AHPI) is finalising import details with J&J currently.

The J&J vaccine's biggest advantage is that it has to be administered only once and is easy to store as well. As per data from the CDC it has a 66.3% efficacy. 

J&J has offered this single-shot vaccine at $25 (approximately ₹1,875) per dose, which AHPI is negotiating. Private hospitals are charging ₹ 780 per dose of Covishield, ₹ 1,410 per dose of Covaxin and ₹ 1,145 per dose of Sputnik

 

Covid 19single dose vaccinevaccineJ&J Covid vaccine

Recommended For You

editorji | Business

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

editorji | Business

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

editorji | Business

GST rates likely unchanged as 57th Council meeting focuses on reforms

editorji | Business

Sensex gains 685 points, Nifty rises 220 points to cross 22,700

editorji | Business

Sensex gains 473 points, Nifty rises 134 points as markets stage recovery